Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-22 04:43:27 UTC |
---|
Update Date | 2016-11-09 01:15:41 UTC |
---|
Accession Number | CHEM017897 |
---|
Identification |
---|
Common Name | Tiagabine hydrochloride |
---|
Class | Small Molecule |
---|
Description | A hydrochloride resulting from the reaction of equimolar amounts of tiagabine and hydrogen chloride. A GABA reuptake inhibitor, it is used for the treatment of epilepsy. |
---|
Contaminant Sources | - ToxCast & Tox21 Chemicals
|
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid hydrochloride | ChEBI | (-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid hydrochloride | ChEBI | (3R)-1-[4,4-Bis(3-methyl-2-thienyl)but-3-en-1-yl]-3-carboxypiperidinium chloride | ChEBI | (3R)-1-[4,4-Bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid monohydrochloride | ChEBI | Abbott 70569.hcl | ChEBI | Abbott-70569.1 | ChEBI | Gabitril | ChEBI | Tiagabine HCL | ChEBI | Tiagabine monohydrochloride | ChEBI | (-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotate hydrochloride | Generator | (-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3-butenyl]nipecotate hydrochloride | Generator | (3R)-1-[4,4-Bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylate monohydrochloride | Generator | N-(4,4-Di(3-methylthien-2-yl)but-3-enyl)nipecotic acid | MeSH | Tiagabine, (S)-isomer | MeSH | (R)-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, hydrochloride | MeSH | Tiagabine | MeSH |
|
---|
Chemical Formula | C20H26ClNO2S2 |
---|
Average Molecular Mass | 412.000 g/mol |
---|
Monoisotopic Mass | 411.109 g/mol |
---|
CAS Registry Number | 145821-59-6 |
---|
IUPAC Name | (3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl]piperidine-3-carboxylic acid hydrochloride |
---|
Traditional Name | tiagabine hydrochloride |
---|
SMILES | Cl.[H][C@]1(CCCN(CCC=C(C2=C(C)C=CS2)C2=C(C)C=CS2)C1)C(O)=O |
---|
InChI Identifier | InChI=1S/C20H25NO2S2.ClH/c1-14-7-11-24-18(14)17(19-15(2)8-12-25-19)6-4-10-21-9-3-5-16(13-21)20(22)23;/h6-8,11-12,16H,3-5,9-10,13H2,1-2H3,(H,22,23);1H/t16-;/m1./s1 |
---|
InChI Key | YUKARLAABCGMCN-PKLMIRHRSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as piperidinecarboxylic acids. Piperidinecarboxylic acids are compounds containing a piperidine ring which bears a carboxylic acid group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Piperidines |
---|
Sub Class | Piperidinecarboxylic acids and derivatives |
---|
Direct Parent | Piperidinecarboxylic acids |
---|
Alternative Parents | |
---|
Substituents | - Piperidinecarboxylic acid
- Thiophene
- Heteroaromatic compound
- Amino acid or derivatives
- Tertiary amine
- Amino acid
- Tertiary aliphatic amine
- Carboxylic acid derivative
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Azacycle
- Organopnictogen compound
- Organic oxygen compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Amine
- Organic oxide
- Hydrocarbon derivative
- Hydrochloride
- Carbonyl group
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
LC-MS/MS | LC-MS/MS Spectrum - , positive | splash10-01ot-2940000000-302d6eb683a2a4f80509 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-03di-0000900000-114887d1f6b53adedb21 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-03di-0000900000-114887d1f6b53adedb21 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-03di-0000900000-114887d1f6b53adedb21 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-03di-0000900000-b9ea9b9dd2300cb33d25 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-03di-0000900000-b9ea9b9dd2300cb33d25 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-03di-0000900000-b9ea9b9dd2300cb33d25 | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DBSALT001255 |
---|
HMDB ID | Not Available |
---|
FooDB ID | Not Available |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Tiagabine |
---|
Chemspider ID | Not Available |
---|
ChEBI ID | 85388 |
---|
PubChem Compound ID | 91274 |
---|
Kegg Compound ID | Not Available |
---|
YMDB ID | Not Available |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | Not Available |
---|